Published in Eur J Immunogenet on February 01, 1997
Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease. Nat Genet (2010) 3.24
Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium. Am J Epidemiol (2010) 2.86
Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci. Nat Genet (2010) 2.74
Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10. Proc Natl Acad Sci U S A (2000) 2.24
Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci U S A (1998) 2.18
Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma. Blood (2006) 2.06
Genome-wide association scan identifies candidate polymorphisms associated with differential response to anti-TNF treatment in rheumatoid arthritis. Mol Med (2008) 1.97
Innate immune gene polymorphisms in tuberculosis. Infect Immun (2012) 1.89
Mycobacterium tuberculosis, macrophages, and the innate immune response: does common variation matter? Immunol Rev (2007) 1.88
Interleukin-10 polymorphism in position -1082 and acute respiratory distress syndrome. Eur Respir J (2006) 1.82
DNA polymorphisms and response to treatment in patients with chronic hepatitis C: results from the HALT-C trial. J Hepatol (2008) 1.71
Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic liver disease. Gut (2000) 1.68
IL10 gene polymorphisms are associated with asthma phenotypes in children. Genet Epidemiol (2004) 1.64
Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component? Gut (2003) 1.58
SNP-SNP interactions in breast cancer susceptibility. BMC Cancer (2006) 1.56
Neuropsychiatric systemic lupus erythematosus is associated with imbalance in interleukin 10 promoter haplotypes. Ann Rheum Dis (1999) 1.55
S100A expression and interleukin-10 polymorphisms are associated with ulcerative colitis and diarrhea predominant irritable bowel syndrome. Dig Dis Sci (2013) 1.52
Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit Rev Immunol (2012) 1.49
Genetic markers for the efficacy of tumour necrosis factor blocking therapy in rheumatoid arthritis. Ann Rheum Dis (2003) 1.48
Association of IL10 and other immune response- and obesity-related genes with prostate cancer in CLUE II. Prostate (2009) 1.45
Timing of adequate antibiotic therapy is a greater determinant of outcome than are TNF and IL-10 polymorphisms in patients with sepsis. Crit Care (2006) 1.43
Mechanisms in prostatitis/chronic pelvic pain syndrome. J Urol (2004) 1.31
Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection. Immunogenetics (2003) 1.30
Multifactorial etiology of gastric cancer. Methods Mol Biol (2012) 1.29
Association of IL-10 polymorphism with severity of illness in community acquired pneumonia. Thorax (2003) 1.28
Leprosy and the human genome. Microbiol Mol Biol Rev (2010) 1.27
Cytokines and systemic lupus erythematosus. Ann Rheum Dis (2000) 1.26
Asthma and genes encoding components of the vitamin D pathway. Respir Res (2009) 1.26
Candidate gene case-control association studies: advantages and potential pitfalls. Br J Clin Pharmacol (2001) 1.24
Cell type specificity and host genetic polymorphisms influence antibody-dependent enhancement of dengue virus infection. J Virol (2010) 1.23
Polymorphisms of some cytokines and chronic hepatitis B and C virus infection. World J Gastroenterol (2009) 1.23
Haplotypes of IL-10 promoter variants are associated with susceptibility to severe malarial anemia and functional changes in IL-10 production. Hum Genet (2008) 1.19
Role of genetic polymorphisms in tumour angiogenesis. Br J Cancer (2002) 1.18
Effect of cytokine gene polymorphism on histological activity index, viral load and response to treatment in patients with chronic hepatitis C genotype 3. World J Gastroenterol (2005) 1.12
Interleukin-10-819 promoter polymorphism in association with gastric cancer risk. BMC Cancer (2012) 1.11
Genetics and pulmonary medicine. 9. Molecular genetics of chronic obstructive pulmonary disease. Thorax (1999) 1.10
Interleukin gene polymorphisms and breast cancer: a case control study and systematic literature review. BMC Cancer (2006) 1.09
Cytokine genetic polymorphisms and prostate cancer aggressiveness. Carcinogenesis (2009) 1.09
IL10 haplotype associated with tuberculin skin test response but not with pulmonary TB. PLoS One (2009) 1.09
IL10 polymorphisms are associated with airflow obstruction in severe alpha1-antitrypsin deficiency. Am J Respir Cell Mol Biol (2007) 1.08
Methodological issues in detecting gene-gene interactions in breast cancer susceptibility: a population-based study in Ontario. BMC Med (2007) 1.08
Interleukin-10 polymorphisms, cancer susceptibility and prognosis. Fam Cancer (2006) 1.08
Retracted Association of cytokine gene polymorphisms with psoriasis in cases from the nile delta of egypt. Indian J Dermatol (2011) 1.08
Alleles carried at positions -819 and -592 of the IL10 promoter affect transcription following stimulation of peripheral blood cells with Streptococcus pneumoniae. Immunogenetics (2003) 1.07
Genetics of food allergy. Curr Opin Pediatr (2009) 1.05
Cytokine gene polymorphisms across tuberculosis clinical spectrum in Pakistani patients. PLoS One (2009) 1.05
IL-10 secretion and sensitivity in normal human intestine and inflammatory bowel disease. J Clin Immunol (2000) 1.05
Raised interleukin-10 is an indicator of poor outcome and enhanced systemic inflammation in patients with acute coronary syndrome. Heart (2007) 1.04
Role of viral and host factors in interferon based therapy of hepatitis C virus infection. Virol J (2013) 1.03
Increased interleukin-10 and interferon-γ levels in Plasmodium vivax malaria suggest a reciprocal regulation which is not altered by IL-10 gene promoter polymorphism. Malar J (2011) 1.03
Genetic polymorphisms in the cytokine genes and risk of hepatocellular carcinoma in low-risk non-Asians of USA. Carcinogenesis (2009) 1.02
Interaction among variant vascular endothelial growth factor (VEGF) and its receptor in relation to prostate cancer risk. Prostate (2010) 1.02
Why interleukin-10 supplementation does not work in Crohn's disease patients. World J Gastroenterol (2013) 1.02
IL-10, IL-6 and CD14 polymorphisms and sepsis outcome in ventilated very low birth weight infants. BMC Med (2006) 1.01
Cytokine gene polymorphisms and the outcome of invasive candidiasis: a prospective cohort study. Clin Infect Dis (2011) 1.00
Interleukin-10 (IL-10) polymorphisms are associated with IL-10 production and clinical malaria in young children. Infect Immun (2012) 0.99
Clinical relevance of the interleukin 10 promoter polymorphisms in Chinese Han patients with major trauma: genetic association studies. Crit Care (2009) 0.98
Findings related to IL-8 and IL-10 gene polymorphisms in a Mexican patient population with irritable bowel syndrome infected with Blastocystis. Parasitol Res (2012) 0.98
Inflammatory bowel disease: the role of inflammatory cytokine gene polymorphisms. Mediators Inflamm (2004) 0.97
Extended IL10 haplotypes and their association with HIV progression to AIDS. Genes Immun (2009) 0.97
Effects of interleukin-10 polymorphisms, Helicobacter pylori infection, and smoking on the risk of noncardia gastric cancer. PLoS One (2012) 0.97
Cytokines and soluble cytokine receptor induction after IL-12 administration in cancer patients. Clin Exp Immunol (2000) 0.97
Association of genetic polymorphisms in the interleukin-10 promoter with risk of prostate cancer in Chinese. BMC Cancer (2010) 0.97
Evaluation of IL10, IL19 and IL20 gene polymorphisms and chronic hepatitis B infection outcome. Int J Immunogenet (2008) 0.96
The interferon gamma gene polymorphism +874 A/T is associated with severe acute respiratory syndrome. BMC Infect Dis (2006) 0.95
Identification of human ccn2 (connective tissue growth factor) promoter polymorphisms. Mol Pathol (2001) 0.95
Genes and abdominal aortic aneurysm. Ann Vasc Surg (2010) 0.95
Interleukin-10 haplotype may predict survival and relapse in resected non-small cell lung cancer. PLoS One (2012) 0.95
The polymorphism rs3024505 proximal to IL-10 is associated with risk of ulcerative colitis and Crohns disease in a Danish case-control study. BMC Med Genet (2010) 0.95
Association of interleukin-10 gene polymorphisms with breast cancer in a Chinese population. J Exp Clin Cancer Res (2010) 0.95
A role for mitogen-activated protein kinase and Ets-1 in the induction of interleukin-10 transcription by human immunodeficiency virus-1 Tat. Immunology (2007) 0.95
Association of 22 cytokine gene polymorphisms with rheumatoid arthritis in population of ethnic Macedonians. Clin Rheumatol (2009) 0.94
IL-10 -1082 G>A: a risk for prostate cancer but may be protective against progression of prostate cancer in North Indian cohort. World J Urol (2009) 0.93
Interleukin-10 promoter haplotypes are differently distributed in the Brazilian versus the Dutch population. Immunogenetics (2003) 0.93
A meta-analysis of interleukin-10-1082 promoter polymorphism associated with gastric cancer risk. DNA Cell Biol (2012) 0.93
Polymorphisms of interleukin-10 promoter are not associated with prognosis of advanced gastric cancer. World J Gastroenterol (2011) 0.93
T-helper 1, T-helper 2, and T-regulatory cytokines gene polymorphisms in irritable bowel syndrome. Inflammation (2010) 0.93
Analysis of eight genes modulating interferon gamma and human genetic susceptibility to tuberculosis: a case-control association study. BMC Infect Dis (2010) 0.93
Etiology of chronic prostatitis/chronic pelvic pain syndrome: psychoimmunoneurendocrine dysfunction (PINE syndrome) or just a really bad infection? World J Urol (2013) 0.93
Role of IL-10 -819(t/c) promoter polymorphism in preeclampsia. Inflammation (2014) 0.92
A comprehensive review on host genetic susceptibility to human papillomavirus infection and progression to cervical cancer. Indian J Hum Genet (2011) 0.92
Organochlorine exposure, immune gene variation, and risk of non-Hodgkin lymphoma. Blood (2008) 0.92
TNF-alpha, TGF-beta1, IL-10, IL-6, gene polymorphisms in latent autoimmune diabetes of adults (LADA) and type 2 diabetes mellitus. J Clin Immunol (2004) 0.92
Polymorphisms in genes controlling inflammation and tissue repair in rheumatoid arthritis: a case control study. BMC Med Genet (2011) 0.92
The TNF (-308A) polymorphism is associated with microchimerism in transfused trauma patients. Blood (2008) 0.92
The interleukin 10 -819C/T polymorphism and cancer risk: a HuGE review and meta-analysis of 73 studies including 15,942 cases and 22,336 controls. OMICS (2013) 0.92
IL10 and IL10 receptor gene variation and outcomes after unrelated and related hematopoietic cell transplantation. Transplantation (2009) 0.92
Investigation of Transforming Growth Factor-β1 Gene Polymorphisms Among Iranian Patients With Chronic Hepatitis C. Hepat Mon (2011) 0.91
Association of cytokine and Toll-like receptor gene polymorphisms with severe malaria in three regions of Cameroon. PLoS One (2013) 0.91
Interleukin (IL)-10, IL-1ra and IL-12 profiles in active and quiescent systemic lupus erythematosus: could longitudinal studies reveal patient subgroups of differing pathology? Clin Exp Immunol (2004) 0.91
Association of polymorphisms of IL and CD14 genes with acute severe pancreatitis and septic shock. World J Gastroenterol (2005) 0.91
Profiles of gene polymorphisms in cytokines and Toll-like receptors with higher risk for gastric cancer. Dig Dis Sci (2012) 0.91
Immunoregulatory networks in human Chagas disease. Parasite Immunol (2014) 0.90
Differential effect of IL10 and TNF{alpha} genotypes on determining susceptibility to discoid and systemic lupus erythematosus. Ann Rheum Dis (2005) 0.90
Pharmacogenetics: implications for therapy in rheumatic diseases. Nat Rev Rheumatol (2011) 0.90
Placental IL-10 dysregulation and association with bronchopulmonary dysplasia risk. Pediatr Res (2009) 0.90
Pneumonia due to Chlamydia trachomatis in the immunocompromised (nude) mouse. J Infect Dis (1981) 3.19
An approach to random mutagenesis of DNA using mixtures of triphosphate derivatives of nucleoside analogues. J Mol Biol (1996) 3.15
Resolution of murine chlamydial genital infection by the adoptive transfer of a biovar-specific, Th1 lymphocyte clone. Reg Immunol (1994) 3.06
Cloning restriction fragments that promote expression of a gene in Bacillus subtilis. J Bacteriol (1981) 3.01
Drug-induced aplastic anemia. Semin Hematol (1973) 2.81
The role of antibody in host defense against the agent of mouse pneumonitis. J Infect Dis (1982) 2.78
Treatment of murine cryptococcosis with liposome-associated amphotericin B. J Infect Dis (1982) 2.36
Role for CD8+ T cells in antichlamydial immunity defined by Chlamydia-specific T-lymphocyte clones. Infect Immun (1994) 2.29
Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation (1998) 2.29
Cellular immunity to the mouse pneumonitis agent. J Infect Dis (1984) 2.28
Effect of gamma interferon on resolution of murine chlamydial genital infection. Infect Immun (1992) 2.24
A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol (2000) 2.21
Nucleotide sequence of a Bacillus pumilus gene specifying chloramphenicol acetyltransferase. Gene (1983) 2.17
TGF-beta(1) genotype and accelerated decline in lung function of patients with cystic fibrosis. Thorax (2000) 2.14
Effect of tobacco and alcohol consumption on the Langerhans cell population of human lingual epithelium determined using a monoclonal antibody against HLADR. J Oral Pathol Med (1991) 2.00
Chloramphenicol-inducible gene expression in Bacillus subtilis. Gene (1983) 1.96
In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. Eur J Immunogenet (1999) 1.94
Genetic control of murine resistance to Toxoplasma gondii. Infect Immun (1978) 1.91
Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus. J Rheumatol (1997) 1.90
Hyperinsulinaemic hypoglycaemia in small for dates babies. Arch Dis Child (1990) 1.86
Strain-dependent differences in murine susceptibility to toxoplasma. Infect Immun (1976) 1.85
Pulmonary infection in the compromised host: part I. Am Rev Respir Dis (1976) 1.82
Amphotericin B in liposomes: a novel therapy for histoplasmosis. Am Rev Respir Dis (1982) 1.77
TNF-alpha gene polymorphism: clinical and biological implications. Microsc Res Tech (2000) 1.77
ARMS-PCR methodologies to determine IL-10, TNF-alpha, TNF-beta and TGF-beta 1 gene polymorphisms. Transpl Immunol (1999) 1.68
Biodiversity at the molecular level: the domains, kingdoms and phyla of life. Philos Trans R Soc Lond B Biol Sci (1994) 1.67
Regulatory regions that control expression of two chloramphenicol-inducible cat genes cloned in Bacillus subtilis. J Bacteriol (1984) 1.66
Interferon in recovery from pneumonia due to Chlamydia trachomatis in the mouse. J Infect Dis (1987) 1.59
Combination therapy of experimental histoplasmosis and cryptococcosis with amphotericin B and ketoconazole. Rev Infect Dis (1981) 1.58
Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component? Gut (2003) 1.58
Role of CD8 T cells in primary Chlamydia infection. Infect Immun (1995) 1.56
Gamma interferon-mediated cytotoxicity related to murine Chlamydia trachomatis infection. Infect Immun (1988) 1.56
Streptococcal infection in piglets: the palatine tonsils as portals of entry for Streptococcus suis. Res Vet Sci (1973) 1.55
IADR Global Oral Health Inequalities Research Agenda (IADR-GOHIRA(R)): a call to action. J Dent Res (2013) 1.53
Ulcerlike lesions of the aorta: imaging features and natural history. Radiology (2001) 1.52
Surgical delay for acute type A dissection with malperfusion. Ann Thorac Surg (1997) 1.50
Expression of Escherichia coli trp genes and the mouse dihydrofolate reductase gene cloned in Bacillus subtilis. Gene (1981) 1.49
The effect of polymorphisms in tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta1 genes in acute hepatic allograft rejection. Transplantation (2000) 1.47
Antibody in host defense against mouse pneumonitis agent (murine Chlamydia trachomatis). Infect Immun (1984) 1.47
Influence of TNFalpha gene polymorphisms on TNFalpha production and disease. Hum Immunol (2001) 1.47
Tumor necrosis factor-alpha plays a role in host defense against Histoplasma capsulatum. J Infect Dis (1990) 1.46
Genotyping for polymorphisms in interferon-gamma, interleukin-10, transforming growth factor-beta 1 and tumour necrosis factor-alpha genes: a technical report. Transpl Immunol (1998) 1.46
Association of cytokine single nucleotide polymorphisms with B7 costimulatory molecules in kidney allograft recipients. Pediatr Transplant (2002) 1.45
Novel polymorphisms in the promoter and 5' UTR regions of the human vascular endothelial growth factor gene. Hum Immunol (1999) 1.45
In situ detection of the Epstein-Barr virus-encoded nuclear antigen 1 in oral hairy leukoplakia and virus-associated carcinomas. J Pathol (1996) 1.43
2'-Fluoro- and 2'-amino-2'-deoxynucleoside 5'-triphosphates as substrates for T7 RNA polymerase. Biochemistry (1992) 1.41
Breath-hold gadolinium-enhanced MR angiography of the abdominal aorta and its major branches. Radiology (1995) 1.41
Portal hypertension in vinyl-chloride production workers. Lancet (1976) 1.40
Transforming growth factor beta (TGF-beta) and obliterative bronchiolitis following pulmonary transplantation. J Heart Lung Transplant (1999) 1.40
Androgen receptor gene mutations identified by SSCP in fourteen subjects with androgen insensitivity syndrome. Hum Mol Genet (1992) 1.40
Low infusion rate digital subtraction angiography to predict regional perfusion in hepatic arterial chemotherapy. Cardiovasc Intervent Radiol (1990) 1.39
Cardiac arrhythmias: diagnosis and treatment. Crit Care Nurse (1988) 1.39
A common protein binds to two silencers 5' to the human beta-globin gene. Nucleic Acids Res (1989) 1.36
The multinucleate cells in giant cell granulomas of the jaw are osteoclasts. Cancer (1988) 1.34
Bacteremic infection in hemodialysis. Arch Intern Med (1979) 1.34
Role of natural killer cells in infection with the mouse pneumonitis agent (murine Chlamydia trachomatis). Infect Immun (1987) 1.33
Chlamydia trachomatis pneumonia induces in vivo production of interleukin-1 and -6. Infect Immun (1992) 1.33
Histoplasma capsulatum infection in nude mice. Infect Immun (1978) 1.31
Spiral CT of renal artery stenosis: comparison of three-dimensional rendering techniques. Radiology (1994) 1.29
Role of cell-mediated immunity in chlamydial infection: implications for ocular immunity. Rev Infect Dis (1986) 1.29
EMG frequency content changes with increasing force and during fatigue in the quadriceps femoris muscle of men and women. J Electromyogr Kinesiol (2003) 1.27
Changes in the male voice at puberty. Arch Dis Child (1997) 1.27
Isolation of the reaction center of Rhodopseudomonas viridis. Biochim Biophys Acta (1969) 1.23
Three-dimensional gadolinium-enhanced MR angiography of the thoracic aorta. AJR Am J Roentgenol (1996) 1.23
Cancer of the uterine cervix may be significantly associated with a gene polymorphism coding for increased IL-10 production. Int J Cancer (2001) 1.23
Grey-scale ultrasonography for monitoring industrial exposure to hepatotoxic agents. Lancet (1975) 1.21
Immunologic studies of disseminated infection with Aspergillus fumigatus in the nude mouse. J Infect Dis (1981) 1.20
Circulating tumour necrosis factor-alpha and interferon-gamma are detectable during acute and convalescent parvovirus B19 infection and are associated with prolonged and chronic fatigue. J Gen Virol (2001) 1.19
Neurilemmoma of the head and neck. Br J Oral Maxillofac Surg (1993) 1.19
Family therapy in general practice: views of referrers and clients. Br J Gen Pract (1992) 1.19
Aortic dissection: CT features that distinguish true lumen from false lumen. AJR Am J Roentgenol (2001) 1.19
Enhancing the catalytic repertoire of nucleic acids: a systematic study of linker length and rigidity. Nucleic Acids Res (2001) 1.18
Effect of human monocytes and macrophages on Trypanosoma cruzi. Immunology (1977) 1.18
Bone mineralization and turnover in children with congenital neutropenia, and its relationship to treatment with recombinant human granulocyte-colony stimulating factor. Br J Haematol (1997) 1.18
An approach to the stereoselective synthesis of Sp-dinucleoside phosphorothioates using phosphotriester chemistry. Nucleic Acids Res (1987) 1.17
Effect of interferon-alpha treatment of chronic hepatitis C on health-related quality of life. Dig Dis Sci (1997) 1.15
Predicting the presence of choledocholithiasis in patients with symptomatic cholelithiasis. Am J Gastroenterol (1996) 1.15
Dominant localization of prostaglandin D receptors on arachnoid trabecular cells in mouse basal forebrain and their involvement in the regulation of non-rapid eye movement sleep. Proc Natl Acad Sci U S A (2001) 1.14
Enhanced expression of mouse dihydrofolate reductase in Bacillus subtilis. Gene (1983) 1.14
Interleukin-10 (IL-10) genotypes in inflammatory bowel disease. Tissue Antigens (1999) 1.13
Antigen-reactive cell opsonization (ARCO) and its role in antibody-mediated immune suppression. Immunol Rev (1980) 1.12
Cytokine gene polymorphisms predict acute graft rejection following renal transplantation. Kidney Int (1999) 1.11
Chlamydia trachomatis pneumonia in the immune, athymic and normal BALB mouse. Br J Exp Pathol (1987) 1.11
Targeted disruption of fibronectin-integrin interactions in human gingival fibroblasts by the RI protease of Porphyromonas gingivalis W50. Infect Immun (1999) 1.10
Vestibular toxicity of gentamicin. Incidence in patients receiving long-term hemodialysis therapy. Arch Intern Med (1978) 1.10
Role of activated macrophages in resistance of mice to infection with Trypanosoma cruzi. J Infect Dis (1976) 1.10
Experimental chemotherapy of histoplasmosis in nude mice. Am Rev Respir Dis (1979) 1.08
Molecular recognition in the minor groove of the DNA helix. Studies on the synthesis of oligonucleotides and polynucleotides containing 3-deaza-2'-deoxyadenosine. Interaction of the oligonucleotides with the restriction endonuclease EcoRV. Nucleic Acids Res (1990) 1.08
The prognosis in aplastic anemia. Blood (1975) 1.08
IMPDH1 gene polymorphisms and association with acute rejection in renal transplant patients. Clin Pharmacol Ther (2007) 1.07
The permeability of human oral mucosa and skin to water. J Dent Res (1989) 1.07
Letter to the editor, "the ethical imperative of addressing oral health disparities: a unifying framework". J Dent Res (2014) 1.07
Interaction of the EcoRV restriction endonuclease with the deoxyadenosine and thymidine bases in its recognition hexamer d(GATATC). Biochemistry (1990) 1.07